{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:39:57Z","timestamp":1761831597075,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jacl.2021.05.004","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T01:28:29Z","timestamp":1622165309000},"page":"540-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cerebrotendinous xanthomatosis, sitosterolemia, Smith-Lemli-Opitz syndrome and the seminal contributions of Gerald Salen, MD (1935\u20132020)"],"prefix":"10.1016","volume":"15","author":[{"given":"Ernst J.","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Stephen","family":"Tint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Barton","family":"Duell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2021.05.004_bib0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-2275(20)39310-X","article-title":"Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids","volume":"6","author":"Grundy","year":"1965","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-2275(20)39311-1","article-title":"Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids","volume":"6","author":"Miettinen","year":"1965","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0003","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-2275(20)43108-6","article-title":"Dietary beta-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies","volume":"9","author":"Grundy","year":"1968","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0004","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1172\/JCI106315","article-title":"The metabolism of \u00df-sitosterol in man","volume":"49","author":"Salen","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2021.05.004_bib0005","first-page":"94","article-title":"Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion of cholesterol metabolism","volume":"78","author":"Salen","year":"1971","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0006","doi-asserted-by":"crossref","first-page":"843","DOI":"10.7326\/0003-4819-75-6-843","article-title":"Cholestanol deposition in cerebrotendinous xanthomatosis: a possible mechanism","volume":"75","author":"Salen","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0007","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1172\/JCI107478","article-title":"The metabolism of cholesterol, cholestanol and bile acids in cerebrotendinous xanthomatosis","volume":"52","author":"Salen","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2021.05.004_bib0008","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-2275(20)36804-8","article-title":"The transformation of 5\u03b1-cholest-7-en-3\u00df-il to cholesterol and cholestanol in cerebrotendinous xanthomatosis","volume":"15","author":"Tint","year":"1974","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-2944(75)90020-4","article-title":"Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis","volume":"14","author":"Salen","year":"1975","journal-title":"Biochem Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0010","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","article-title":"Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid","volume":"311","author":"Berginer","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0011","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJM198705143162002","article-title":"Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid","volume":"16","author":"Salen","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0012","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/S0021-9258(20)89518-0","article-title":"Mutations in the human sterol 27- hydroxylase gene underlie cerebrotendinous xanthomatosis","volume":"266","author":"Cali","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2021.05.004_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-2275(20)31675-8","article-title":"Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees","volume":"42","author":"Lee","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0014","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2021.05.004_bib0015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","article-title":"Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis","volume":"12","author":"Duell","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.05.004_bib0016","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0016-5085(19)30493-7","article-title":"The effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans","volume":"78","author":"Salen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2021.05.004_bib0017","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/0003-4819-97-3-351","article-title":"Ursodeoxycholic acid: a clinical trial of a safe and effective agent for dissolving cholesterol gallstones","volume":"97","author":"Tint","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0018","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198903093201010","article-title":"Nonsurgical treatment of gallstones","volume":"320","author":"Salen","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0019","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1172\/JCI107640","article-title":"\u03b2-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters","volume":"53","author":"Bhattacharyya","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2021.05.004_bib0020","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0022-2275(20)34286-3","article-title":"Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis","volume":"26","author":"Salen","year":"1985","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0021","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0022-2275(20)38259-6","article-title":"Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis","volume":"30","author":"Salen","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0023","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jacl.2021.05.004_bib0022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/83799","article-title":"Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption","volume":"27","author":"Lee","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2021.05.004_bib0024","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/321294","article-title":"Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively","volume":"69","author":"Lu","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacl.2021.05.004_bib0025","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000116766.31036.03","article-title":"Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia","volume":"109","author":"Salen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2021.05.004_bib0026","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacl.2017.10.013","article-title":"The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred","volume":"12","author":"Brinton","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.05.004_bib0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199401133300205","article-title":"Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome","volume":"330","author":"Tint","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2021.05.004_bib0028","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0022-2275(20)39146-X","article-title":"Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome","volume":"37","author":"Salen","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.05.004_bib0029","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<311::AID-AJMG12>3.0.CO;2-W","article-title":"Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial","volume":"68","author":"Irons","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jacl.2021.05.004_bib0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/hmg\/9.9.1385","article-title":"Spectrum of \u03947-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome","volume":"9","author":"Yu","year":"2000","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:35:52Z","timestamp":1761831352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287421000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1933287421000751"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2021.05.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrotendinous xanthomatosis, sitosterolemia, Smith-Lemli-Opitz syndrome and the seminal contributions of Gerald Salen, MD (1935\u20132020)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2021.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}